Browse by Title

All times listed are Central Daylight Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.

Browse by Title

Type here to filter the list

K
Key factors in optimizing the dose of Baricitinib in rheumatoid arthritis: a study based on routine clinical practice and its therapeutic implications (2269)

Daniel Campos-Martin, n/a (he/him/his) – Rheumatology Department, Donostia University Hospital ### 2766918###Abstract Poster Presenter######Rheumatology Department, Donostia University Hospital###
Abstract Poster Presenter: Daniel Campos-Martin, n/a (he/him/his) – Rheumatology Department, Donostia University Hospital
### he/him/his 2269
Kidney Transplantation In Lupus Nephritis. Multicenter Study Of 103 Patients (0639)

Vanesa Calvo Río, MD – Hospital Universitario Marqués de Valdecilla, Immunopathology group, IDIVAL ### 1420921###Abstract Poster Presenter######Hospital Universitario Marqués de Valdecilla, Immunopathology group, IDIVAL###
Abstract Poster Presenter: Vanesa Calvo Río, MD – Hospital Universitario Marqués de Valdecilla, Immunopathology group, IDIVAL
### 0639
Kidney-Related Outcomes With Obinutuzumab in Patients With Active Lupus Nephritis: A Pre-Specified Exploratory Analysis of the Clinical Trial Data (1521)

Brad Rovin, MD – The Ohio State University ### 992717###Abstract Poster Presenter######The Ohio State University###
Abstract Poster Presenter: Brad Rovin, MD – The Ohio State University
### 1521
Kidney-Specific Four-Protein Index Outperforms Conventional Measures for Detecting Early Kidney Damage in Lupus Nephritis and Diabetic Kidney Disease (2427)

Sepehr Taghavi, MSc – Exagen Inc ### 2464998###Abstract Poster Presenter######Exagen Inc###
Abstract Poster Presenter: Sepehr Taghavi, MSc – Exagen Inc
### 2427
Kinematics Underlying IBM-induced Dysphagia (2064)

Kevin Renz Ambrocio, MS – University of Pittsburgh ### 2764505###Abstract Poster Presenter######University of Pittsburgh###
Abstract Poster Presenter: Kevin Renz Ambrocio, MS – University of Pittsburgh
### 2064
KITE-363: An Autologous Anti-CD19/CD20 CAR-T Product for the Treatment of Autoimmune Rheumatic Diseases (0002)

Brian Kim, MS – Kite, a Gilead Company ### 2762092###Abstract Poster Presenter######Kite, a Gilead Company###
Abstract Poster Presenter: Brian Kim, MS – Kite, a Gilead Company
### 0002
Knee Symptom Phenotyping Incorporating Pain and Function across Different Levels of WOMAC Function in Two Cohorts: Data from the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI) (0325)

Kent Kwoh, MD, MACR – University of Arizona ### 684523###Abstract Poster Presenter######University of Arizona###
Abstract Poster Presenter: Kent Kwoh, MD, MACR – University of Arizona
### 0325
Knowledge of Fertility and Infertility Treatments Among Physicians Treating Women with Rheumatic Diseases: FIT-KS Survey (2171)

Andres Manuel Ortiz-Rios, Sr, BS (he/him/his) – Facultad de Medicina, Universidad Autonoma de Nuevo Leon ### 2762839###Abstract Poster Presenter######Facultad de Medicina, Universidad Autonoma de Nuevo Leon###
Abstract Poster Presenter: Andres Manuel Ortiz-Rios, Sr, BS (he/him/his) – Facultad de Medicina, Universidad Autonoma de Nuevo Leon
### he/him/his 2171
Krebs von den Lungen 6 levels (∆KL6) is a reliable marker of disease activity and response to therapy in CTD-ILD (2030)

Fredeswinda Romero, MD (she/her/hers) – University Hospital Fundaci�n Jim�nez D�az\"\" ### 1427466###Abstract Poster Presenter######University Hospital Fundaci�n Jim�nez D�az\"\"###
Abstract Poster Presenter: Fredeswinda Romero, MD (she/her/hers) – University Hospital Fundaci�n Jim�nez D�az\"\"
### she/her/hers 2030
Krebs von den Lungen-6 (KL-6) as a Potential Diagnostic Biomarker of Lung Disease in Pediatric Systemic Juvenile Idiopathic Arthritis: Preliminary Findings from a Multisite US Cohort (2134)

Eileen Rife, MD – University of Alabama at Birmingham ### 2764814###Abstract Poster Presenter######University of Alabama at Birmingham###
Abstract Poster Presenter: Eileen Rife, MD – University of Alabama at Birmingham
### 2134
KT501, a CD19/BCMA/CD3 trispecific antibody, leads to rapid and deep B-cell depletion with well-tolerated safety (0012)

Min Bao, MD – Kali Therapeutics ### 2762237###Abstract Poster Presenter######Kali Therapeutics###
Abstract Poster Presenter: Min Bao, MD – Kali Therapeutics
### 0012
KT502, a novel CD19-directed TCE (T-cell engager), leads to rapid and deep B-cell depletion with low cytokine release (0011)

Min Bao, MD – Kali Therapeutics ### 2762237###Abstract Poster Presenter######Kali Therapeutics###
Abstract Poster Presenter: Min Bao, MD – Kali Therapeutics
### 0011